Sodium-glucose cotransporter 2 inhibitor canagliflozin attenuates lung cancer cell proliferation in vitro
In conclusion, SGLT2 is expressed in human lung cancer tissue and cell lines, and the SGLT2 inhibitor, canagliflozin, attenuated prolife ration of A549 lung cancer cells by inhibiting cell cycle progression in vitro but not in vivo.
Source: Diabetology International - Category: Endocrinology Source Type: research
More News: Canagliflozin | Cancer | Cancer & Oncology | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Endocrinology | Insulin | Invokana | Lung Cancer | Oral Cancer | SGLT2 Inhibitors | Sodium | Statistics | Study